First Therapy Approved to Treat Rare Blood Clotting Disorder
FDA has approved Cablivi (caplacizumab-yhdp) injection, the first therapy specifically indicated, in combination with plasma exchange and immunosuppressive
therapy, for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura.
FDA Approves Hepatitis A and Measles Exposure Drug
FDA has approved Grifols’ GamaSTAN to treat people exposed to measles and the hepatitis A viruses.
Majority of Vaccination Bills Propose Increasing Exemptions, But Most Enacted Limit Exemptions
Although more antivaccination legislation was introduced between 2011 and 2017, bills that limited vaccine exemptions were significantly more likely to be enacted.
Subcutaneous Lanadelumab Treatment Reduces Attack Rate in Patients with Hereditary Angioedema
Subcutaneous administration of lanadelumab, an investigational monoclonal antibody intended for the prevention of attacks in patients with type I or II hereditary angioedema (HAE), significantly reduced the mean number of attacks compared to placebo treatment.
Study Finds Nasal Flu Vaccine Less Effective Than the Flu Shot
A recent meta-analysis of pooled individual patient-level data, researchers found reduced effectiveness of the quadrivalent live-attenuated influenza vaccine (LAIV4) against influenza A/H1N1pdm09 compared with inactivated influenza vaccine (IIV) in children and adolescents.
IVIG Therapy Reduces In-Hospital Mortality and Ventricular Function Loss in Patients with Acute Myocarditis: Meta-Analysis
Investigators at the Huazhong University of Science and Technology conducted a meta-analysis of published clinical trials that evaluated IVIG therapy in acute myocarditis.
Romiplostim Approved to Treat Pediatric Patients with Immune Thrombocytopenia
FDA has approved Amgen’s romiplostim to treat pediatric patients ages 1 year and older with immune thrombocytopenia for a minimum of six months and who have had an insufficient response to corticosteroids, immune globulin or splenectomy.
Human Vaccines Project Launches Study of How the Immune System Responds to the Flu
The Human Vaccine Project aims to understand how the human immune system can develop longer-lasting protection against influenza.
FDA Approves Drug to Treat Acute Myeloid Leukemia
FDA has approved Xospata (gilteritinib) to treat adult patients with relapsed or refractory acute myeloid leukemia with a certain genetic mutation.
Study Says Glaucoma May Be an Autoimmune Disease
A study conducted by MIT and the Massachusetts Eye and Ear has found glaucoma may be an autoimmune disorder.